Fig. 2From: Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort studyForest plot of the risk of outcomes among those exposed to Paxlovid compared to non-PaxlovidBack to article page